` 8VP1 (Avricore Health Inc) vs DAX Index Comparison - Alpha Spread

8VP1
vs
D
DAX Index

Over the past 12 months, 8VP1 has significantly outperformed DAX Index, delivering a return of +36% compared to the DAX Index's +11% growth.

Stocks Performance
8VP1 vs DAX Index

Loading
8VP1
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
8VP1 vs DAX Index

Loading
8VP1
DAX Index
Difference
www.alphaspread.com

Performance By Year
8VP1 vs DAX Index

Loading
8VP1
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Avricore Health Inc vs Peers

DAX Index
8VP1
VEEV
EIS
SMART
CIM
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Avricore Health Inc
Glance View

Market Cap
3.7m EUR
Industry
Health Care

Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies (POCT). The firm's flagship offering includes HealthTab. HealthTab is a point-of-care testing solution that combines point-of-care technologies with a cloud-based platform for global health issues. HealthTab offers a screening system, designed to support pharmacist role. The company enables the patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a network is the point-of-care based system, which provides direct consumer consent on patient demographics, as well as real-time reporting on data. The firm's subsidiary includes Vanc Marine Pharmaceuticals Inc. and HealthTab Inc.

8VP1 Intrinsic Value
0.0556 EUR
Undervaluation 33%
Intrinsic Value
Price
Back to Top